Gland Pharma Ltd News & Stock Insights Today

The European business reported a 54 percent year on year surge in topline during the quarter.

Here are some of the stocks that may see significant price movement today: Infosys, Tata Steel, Cipla Limited, etc.

Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.